Literature DB >> 3518606

Clinical pharmacology of nicotine.

N L Benowitz.   

Abstract

Nicotine is the primary reason why people consume tobacco products and it may contribute to causation of tobacco-related diseases. This chapter reviews the human pharmacology of nicotine, the evidence for a role of nicotine in human disease, and the use of nicotine (gum) as a therapeutic agent in smoking cessation therapy.

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3518606     DOI： 10.1146/annurev.me.37.020186.000321

Source DB:  PubMed          Journal:  Annu Rev Med        ISSN： 0066-4219            Impact factor:   13.739


  36 in total

1.  Effects of repeated withdrawal episodes, nicotine dose, and duration of nicotine exposure on the severity and duration of nicotine withdrawal in rats.

Authors:  Karen L Skjei; Athina Markou
Journal:  Psychopharmacology (Berl)       Date:  2003-04-24       Impact factor: 4.530

2.  The influence of chronic nicotine treatment on stress-induced gastric ulceration and emptying rate in rats.

Authors:  B S Qiu; C H Cho; C W Ogle
Journal:  Experientia       Date:  1992-04-15

3.  Depression of salivary epidermal growth factor by smoking.

Authors:  P D Jones; N Hudson; C J Hawkey
Journal:  BMJ       Date:  1992-02-22

Review 4.  Non-steroidal anti-inflammatory drugs and peptic ulcers.

Authors:  C J Hawkey
Journal:  BMJ       Date:  1990-02-03

5.  Risk factor paradox: No prognostic impact of arterial hypertension and smoking in patients with ventricular tachyarrhythmias.

Authors:  Kathrin Weidner; Michael Behnes; Jonas Rusnak; Gabriel Taton; Tobias Schupp; Linda Reiser; Armin Bollow; Thomas Reichelt; Dominik Ellguth; Niko Engelke; Philip Kuche; Jorge Hoppner; Ibrahim El-Battrawy; Siegfried Lang; Christoph A Nienaber; Kambis Mashayekhi; Dennis Ferdinand; Christel Weiß; Martin Borggrefe; Ibrahim Akin
Journal:  Cardiol J       Date:  2018-12-19       Impact factor: 2.737

Review 6.  Alzheimer's disease and age-related memory decline (preclinical).

Authors:  Alvin V Terry; Patrick M Callahan; Brandon Hall; Scott J Webster
Journal:  Pharmacol Biochem Behav       Date:  2011-02-24       Impact factor: 3.533

7.  Influence of nicotine on tissue trace element concentrations and tissue antioxidant defense.

Authors:  M A Dubick; C L Keen
Journal:  Biol Trace Elem Res       Date:  1991-11       Impact factor: 3.738

Review 8.  The nicotine inhaler: clinical pharmacokinetics and comparison with other nicotine treatments.

Authors:  N G Schneider; R E Olmstead; M A Franzon; E Lunell
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 6.447

9.  A new role for nicotine: selective inhibition of thromboxane formation by direct interaction with thromboxane synthase in human promyelocytic leukaemia cells differentiating into macrophages.

Authors:  M Goerig; V Ullrich; G Schettler; C Foltis; A Habenicht
Journal:  Clin Investig       Date:  1992 Mar-Apr

10.  The pituri story: a review of the historical literature surrounding traditional Australian Aboriginal use of nicotine in Central Australia.

Authors:  Angela Ratsch; Kathryn J Steadman; Fiona Bogossian
Journal:  J Ethnobiol Ethnomed       Date:  2010-09-12       Impact factor: 2.733
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.